Abstract
Summary
Multimodal imaging or multiplexed imaging refers to simultaneous production of signals for more than one imaging technique. For example, one could combine using optical, magnetic, and radioactive reporters to be detected by SPECT, MRI, and PET.
LPI (LP Information)' newest research report, the “3D Multimodality Imaging Industry Forecast” looks at past sales and reviews total world 3D Multimodality Imaging sales in 2022, providing a comprehensive analysis by region and market sector of projected 3D Multimodality Imaging sales for 2023 through 2029. With 3D Multimodality Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 3D Multimodality Imaging industry.
This Insight Report provides a comprehensive analysis of the global 3D Multimodality Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 3D Multimodality Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 3D Multimodality Imaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 3D Multimodality Imaging and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 3D Multimodality Imaging.
The global 3D Multimodality Imaging market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key 3D Multimodality Imaging players cover Siemens AG, GE Healthcare, Koninklijke Philips N.V., Bruker Corporation, Canon, Mediso, MILabs B.V., MR Solutions and Northridge Tri-Modality Imaging, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of 3D Multimodality Imaging market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
PET-CT
SPECT-CT
PET-MR
OCT
Other
Segmentation by application
Hospitals
Diagnostic Centers
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens AG
GE Healthcare
Koninklijke Philips N.V.
Bruker Corporation
Canon
Mediso
MILabs B.V.
MR Solutions
Northridge Tri-Modality Imaging
PerkinElmer
Heidelberg Engineering
Infraredx (Nipro Corporation)
Neusoft Medical Systems
Spectrum Dynamics Medical
Topcon Corporation
Zeiss Group
LPI (LP Information)' newest research report, the “3D Multimodality Imaging Industry Forecast” looks at past sales and reviews total world 3D Multimodality Imaging sales in 2022, providing a comprehensive analysis by region and market sector of projected 3D Multimodality Imaging sales for 2023 through 2029. With 3D Multimodality Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 3D Multimodality Imaging industry.
This Insight Report provides a comprehensive analysis of the global 3D Multimodality Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 3D Multimodality Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 3D Multimodality Imaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 3D Multimodality Imaging and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 3D Multimodality Imaging.
The global 3D Multimodality Imaging market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for 3D Multimodality Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key 3D Multimodality Imaging players cover Siemens AG, GE Healthcare, Koninklijke Philips N.V., Bruker Corporation, Canon, Mediso, MILabs B.V., MR Solutions and Northridge Tri-Modality Imaging, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of 3D Multimodality Imaging market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
PET-CT
SPECT-CT
PET-MR
OCT
Other
Segmentation by application
Hospitals
Diagnostic Centers
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens AG
GE Healthcare
Koninklijke Philips N.V.
Bruker Corporation
Canon
Mediso
MILabs B.V.
MR Solutions
Northridge Tri-Modality Imaging
PerkinElmer
Heidelberg Engineering
Infraredx (Nipro Corporation)
Neusoft Medical Systems
Spectrum Dynamics Medical
Topcon Corporation
Zeiss Group
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 3D Multimodality Imaging Market Size 2018-2029
2.1.2 3D Multimodality Imaging Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 3D Multimodality Imaging Segment by Type
2.2.1 PET-CT
2.2.2 SPECT-CT
2.2.3 PET-MR
2.2.4 OCT
2.2.5 Other
2.3 3D Multimodality Imaging Market Size by Type
2.3.1 3D Multimodality Imaging Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global 3D Multimodality Imaging Market Size Market Share by Type (2018-2023)
2.4 3D Multimodality Imaging Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Centers
2.4.3 Other
2.5 3D Multimodality Imaging Market Size by Application
2.5.1 3D Multimodality Imaging Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global 3D Multimodality Imaging Market Size Market Share by Application (2018-2023)
3 3D Multimodality Imaging Market Size by Player
3.1 3D Multimodality Imaging Market Size Market Share by Players
3.1.1 Global 3D Multimodality Imaging Revenue by Players (2018-2023)
3.1.2 Global 3D Multimodality Imaging Revenue Market Share by Players (2018-2023)
3.2 Global 3D Multimodality Imaging Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 3D Multimodality Imaging by Regions
4.1 3D Multimodality Imaging Market Size by Regions (2018-2023)
4.2 Americas 3D Multimodality Imaging Market Size Growth (2018-2023)
4.3 APAC 3D Multimodality Imaging Market Size Growth (2018-2023)
4.4 Europe 3D Multimodality Imaging Market Size Growth (2018-2023)
4.5 Middle East & Africa 3D Multimodality Imaging Market Size Growth (2018-2023)
5 Americas
5.1 Americas 3D Multimodality Imaging Market Size by Country (2018-2023)
5.2 Americas 3D Multimodality Imaging Market Size by Type (2018-2023)
5.3 Americas 3D Multimodality Imaging Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 3D Multimodality Imaging Market Size by Region (2018-2023)
6.2 APAC 3D Multimodality Imaging Market Size by Type (2018-2023)
6.3 APAC 3D Multimodality Imaging Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe 3D Multimodality Imaging by Country (2018-2023)
7.2 Europe 3D Multimodality Imaging Market Size by Type (2018-2023)
7.3 Europe 3D Multimodality Imaging Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 3D Multimodality Imaging by Region (2018-2023)
8.2 Middle East & Africa 3D Multimodality Imaging Market Size by Type (2018-2023)
8.3 Middle East & Africa 3D Multimodality Imaging Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global 3D Multimodality Imaging Market Forecast
10.1 Global 3D Multimodality Imaging Forecast by Regions (2024-2029)
10.1.1 Global 3D Multimodality Imaging Forecast by Regions (2024-2029)
10.1.2 Americas 3D Multimodality Imaging Forecast
10.1.3 APAC 3D Multimodality Imaging Forecast
10.1.4 Europe 3D Multimodality Imaging Forecast
10.1.5 Middle East & Africa 3D Multimodality Imaging Forecast
10.2 Americas 3D Multimodality Imaging Forecast by Country (2024-2029)
10.2.1 United States 3D Multimodality Imaging Market Forecast
10.2.2 Canada 3D Multimodality Imaging Market Forecast
10.2.3 Mexico 3D Multimodality Imaging Market Forecast
10.2.4 Brazil 3D Multimodality Imaging Market Forecast
10.3 APAC 3D Multimodality Imaging Forecast by Region (2024-2029)
10.3.1 China 3D Multimodality Imaging Market Forecast
10.3.2 Japan 3D Multimodality Imaging Market Forecast
10.3.3 Korea 3D Multimodality Imaging Market Forecast
10.3.4 Southeast Asia 3D Multimodality Imaging Market Forecast
10.3.5 India 3D Multimodality Imaging Market Forecast
10.3.6 Australia 3D Multimodality Imaging Market Forecast
10.4 Europe 3D Multimodality Imaging Forecast by Country (2024-2029)
10.4.1 Germany 3D Multimodality Imaging Market Forecast
10.4.2 France 3D Multimodality Imaging Market Forecast
10.4.3 UK 3D Multimodality Imaging Market Forecast
10.4.4 Italy 3D Multimodality Imaging Market Forecast
10.4.5 Russia 3D Multimodality Imaging Market Forecast
10.5 Middle East & Africa 3D Multimodality Imaging Forecast by Region (2024-2029)
10.5.1 Egypt 3D Multimodality Imaging Market Forecast
10.5.2 South Africa 3D Multimodality Imaging Market Forecast
10.5.3 Israel 3D Multimodality Imaging Market Forecast
10.5.4 Turkey 3D Multimodality Imaging Market Forecast
10.5.5 GCC Countries 3D Multimodality Imaging Market Forecast
10.6 Global 3D Multimodality Imaging Forecast by Type (2024-2029)
10.7 Global 3D Multimodality Imaging Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Siemens AG
11.1.1 Siemens AG Company Information
11.1.2 Siemens AG 3D Multimodality Imaging Product Offered
11.1.3 Siemens AG 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Siemens AG Main Business Overview
11.1.5 Siemens AG Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare 3D Multimodality Imaging Product Offered
11.2.3 GE Healthcare 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Information
11.3.2 Koninklijke Philips N.V. 3D Multimodality Imaging Product Offered
11.3.3 Koninklijke Philips N.V. 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Koninklijke Philips N.V. Main Business Overview
11.3.5 Koninklijke Philips N.V. Latest Developments
11.4 Bruker Corporation
11.4.1 Bruker Corporation Company Information
11.4.2 Bruker Corporation 3D Multimodality Imaging Product Offered
11.4.3 Bruker Corporation 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bruker Corporation Main Business Overview
11.4.5 Bruker Corporation Latest Developments
11.5 Canon
11.5.1 Canon Company Information
11.5.2 Canon 3D Multimodality Imaging Product Offered
11.5.3 Canon 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Canon Main Business Overview
11.5.5 Canon Latest Developments
11.6 Mediso
11.6.1 Mediso Company Information
11.6.2 Mediso 3D Multimodality Imaging Product Offered
11.6.3 Mediso 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Mediso Main Business Overview
11.6.5 Mediso Latest Developments
11.7 MILabs B.V.
11.7.1 MILabs B.V. Company Information
11.7.2 MILabs B.V. 3D Multimodality Imaging Product Offered
11.7.3 MILabs B.V. 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 MILabs B.V. Main Business Overview
11.7.5 MILabs B.V. Latest Developments
11.8 MR Solutions
11.8.1 MR Solutions Company Information
11.8.2 MR Solutions 3D Multimodality Imaging Product Offered
11.8.3 MR Solutions 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 MR Solutions Main Business Overview
11.8.5 MR Solutions Latest Developments
11.9 Northridge Tri-Modality Imaging
11.9.1 Northridge Tri-Modality Imaging Company Information
11.9.2 Northridge Tri-Modality Imaging 3D Multimodality Imaging Product Offered
11.9.3 Northridge Tri-Modality Imaging 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Northridge Tri-Modality Imaging Main Business Overview
11.9.5 Northridge Tri-Modality Imaging Latest Developments
11.10 PerkinElmer
11.10.1 PerkinElmer Company Information
11.10.2 PerkinElmer 3D Multimodality Imaging Product Offered
11.10.3 PerkinElmer 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 PerkinElmer Main Business Overview
11.10.5 PerkinElmer Latest Developments
11.11 Heidelberg Engineering
11.11.1 Heidelberg Engineering Company Information
11.11.2 Heidelberg Engineering 3D Multimodality Imaging Product Offered
11.11.3 Heidelberg Engineering 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Heidelberg Engineering Main Business Overview
11.11.5 Heidelberg Engineering Latest Developments
11.12 Infraredx (Nipro Corporation)
11.12.1 Infraredx (Nipro Corporation) Company Information
11.12.2 Infraredx (Nipro Corporation) 3D Multimodality Imaging Product Offered
11.12.3 Infraredx (Nipro Corporation) 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Infraredx (Nipro Corporation) Main Business Overview
11.12.5 Infraredx (Nipro Corporation) Latest Developments
11.13 Neusoft Medical Systems
11.13.1 Neusoft Medical Systems Company Information
11.13.2 Neusoft Medical Systems 3D Multimodality Imaging Product Offered
11.13.3 Neusoft Medical Systems 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Neusoft Medical Systems Main Business Overview
11.13.5 Neusoft Medical Systems Latest Developments
11.14 Spectrum Dynamics Medical
11.14.1 Spectrum Dynamics Medical Company Information
11.14.2 Spectrum Dynamics Medical 3D Multimodality Imaging Product Offered
11.14.3 Spectrum Dynamics Medical 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Spectrum Dynamics Medical Main Business Overview
11.14.5 Spectrum Dynamics Medical Latest Developments
11.15 Topcon Corporation
11.15.1 Topcon Corporation Company Information
11.15.2 Topcon Corporation 3D Multimodality Imaging Product Offered
11.15.3 Topcon Corporation 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Topcon Corporation Main Business Overview
11.15.5 Topcon Corporation Latest Developments
11.16 Zeiss Group
11.16.1 Zeiss Group Company Information
11.16.2 Zeiss Group 3D Multimodality Imaging Product Offered
11.16.3 Zeiss Group 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Zeiss Group Main Business Overview
11.16.5 Zeiss Group Latest Developments
12 Research Findings and Conclusion